LAM Therapeutics, a 4Catalyzer company that develops drugs for cancer and rare diseases, announced that it has closed $58 million in Series C financing. 4Catalyzer is Connecticut's premier biotechnology incubator and has raised over a quarter billion dollars to support its current class of startups.